This paper is in the following e-collection/theme issue:

Formative Evaluation of Digital Health Interventions (2198) Patient-Reported Outcome Measures (PROMs) (275)

Published on in Vol 6, No 5 (2022): May

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/21458, first published .
Implementing Symptom Management Follow-up Using an Electronic Patient-Reported Outcome Platform in Outpatients With Advanced Cancer: Longitudinal Single-Center Prospective Study

Implementing Symptom Management Follow-up Using an Electronic Patient-Reported Outcome Platform in Outpatients With Advanced Cancer: Longitudinal Single-Center Prospective Study

Implementing Symptom Management Follow-up Using an Electronic Patient-Reported Outcome Platform in Outpatients With Advanced Cancer: Longitudinal Single-Center Prospective Study

Authors of this article:

Lili Tang1 Author Orcid Image ;   Yi He1 Author Orcid Image ;   Ying Pang1 Author Orcid Image ;   Zhongge Su1 Author Orcid Image ;   Jinjiang Li1 Author Orcid Image ;   Yening Zhang1 Author Orcid Image ;   Xu Wang2 Author Orcid Image ;   Xinkun Han1 Author Orcid Image ;   Yan Wang1 Author Orcid Image ;   Zimeng Li1 Author Orcid Image ;   Shuangzhi He1 Author Orcid Image ;   Lili Song1 Author Orcid Image ;   Yuhe Zhou1 Author Orcid Image ;   Bingmei Wang1 Author Orcid Image ;   Xiumin Li1 Author Orcid Image
Article Authors Cited by (7) Tweetations (4) Metrics

Lili Tang   1 * , MD ;   Yi He   1 * , MD ;   Ying Pang   1 , MSc ;   Zhongge Su   1 , MSc ;   Jinjiang Li   1 , MSc ;   Yening Zhang   1 , MSc ;   Xu Wang   2 , MBA ;   Xinkun Han   1 , BSc ;   Yan Wang   1 , MD ;   Zimeng Li   1 , MD ;   Shuangzhi He   1 , BSc ;   Lili Song   1 , MD ;   Yuhe Zhou   1 , MSc ;   Bingmei Wang   1 , BSc ;   Xiumin Li   1 , BSc

1 Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Department of Psycho-oncology, Peking University Cancer Hospital & Institute, Beijing, China

2 ePRO Vision, Health Technology Co, Ltd, Beijing, China

*these authors contributed equally

Corresponding Author:

  • Lili Tang, MD
  • Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education)
  • Department of Psycho-oncology
  • Peking University Cancer Hospital & Institute
  • 52 Fucheng Road
  • Beijing, 100142
  • China
  • Phone: 86 1088196648
  • Fax: 86 1088196648
  • Email: tanglili_cpos@126.com